Aspirin 'cuts risk of cancer by up to half'
A trial involving more than half a million people found long-term aspirin users cut their risk of liver and oesophageal cancer by almost half, while their odds of getting bowel cancer fell by a quarter.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Aspirin | Bowel Cancer | Cancer | Cancer & Oncology | Esophagus Cancer | Health | Liver | Urology & Nephrology